November 01, 2025
The U.S. digital health market size is forecast to increase from USD 98.69 billion in 2026 to USD 238.65 billi...
Read MoreNovember 01, 2025
The simulators market size is projected to expand from USD 14.72 billion in 2026 to USD 25.53 billion by 2034,...
Read MoreNovember 01, 2025
The osteoarthritis therapeutics market size is expected to see growth from USD 11.92 billion in 2026 to USD 24...
Read MoreOctober 01, 2025
The medical device CMO and CDMO market size is is set to grow significantly, driven by evolving consumer prefe...
Read MoreNovember 06, 2025
Market insights predict the global inhalation and nasal spray generic drugs industry will increase from USD 25.18 billion in 2025 to USD 59.35 billion by 2035, achieving a CAGR of 8.99%. The inhalation and nasal spray generic drugs market is expanding due to the growing availability of affordable generic alternatives and technological innovations. ...
November 06, 2025
Market insights predict, the polycystic ovary syndrome supplements industry is expected to grow from USD 1.32 billion in 2025 to USD 5.05 billion by 2035, driven by a CAGR of 14.34%. The market is driven by rising awareness, lifestyle-focused interventions, and demand for natural and supportive therapies. The use of PCOS supplements helps to manage...
November 06, 2025
According to market projections, the global HPV-associated disorders market, valued at USD 21.51 billion in 2025, is anticipated to reach USD 33.88 billion by 2035, growing at a CAGR of 4.65% over the next decade. The HPV HPV-associated disorders Market is growing due to increasing awareness of HPV-related diseases. North America is leading due to ...
November 06, 2025
Projections indicate that, the global liposomal doxorubicin market will increase from USD 1.47 billion in 2025 to USD 2.37 billion by 2035, experiencing a CAGR of 4.96% over the next 10 years. The market is growing due to rising cancer prevalence and increasing adoption of targeting drug delivery systems for safer and more effective treatment. Nort...
November 06, 2025
Market insights predict, the dengue vaccine industry is expected to grow from USD 751.01 million in 2025 to USD 2297.33 million by 2035, driven by a CAGR of 11.74%. The dengue vaccine market is growing due to a rise in government initiatives to promote dengue vaccination campaigns. North America dominates the market due to a strong presence of the ...
November 06, 2025
Based on market forecasts, the bioanalytical testing services sector will expand from USD 4.54 billion in 2025 to USD 18.66 billion by 2035, experiencing a CAGR of 15.54%. The increasing number of clinical trials and technological advancements drives the global market. The presence of key players and state-of-the-art research and development facili...
November 06, 2025
Market insights predict the global sciatica treatment industry will increase from USD 796 million in 2025 to USD 1171.76 million by 2035, achieving a CAGR of 3.94%. The market is driven by sedentary lifestyles and aging populations, fuel demand for effective pain management solutions. North America is leading the global market, driven by robust hea...
November 06, 2025
Based on market forecasts, the global drug repurposing market, projected at USD 636.95 million in 2025, is expected to reach USD 2506.64 million by 2035, growing at a CAGR of 14.76% over the forecast period. The world is demanding faster, more affordable alternatives for the traditional drug development process. North America registered dominance w...
November 05, 2025
According to forecasts, the global TD vaccine market will grow from USD 6.17 billion in 2024 to USD 10.68 billion by 2034, with an expected CAGR of 5.64%. Increasing global health programs and the development of combination vaccines are fueling demand for the Td vaccine around the globe. However, the Asia Pacific dominated market due to high birth ...
November 05, 2025
Market insights predict the global cellular health screening industry will increase from USD 3.37 billion in 2024 to USD 8.14 billion by 2034, achieving a CAGR of 9.24%. The rising prevalence of chronic disorders and technological advancements drive the global market. Whereas, the presence of a robust healthcare infrastructure and increasing invest...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com